세계의 신속 진단 시장 보고서(2025년)

Rapid diagnostics are medical tests designed to swiftly detect the presence or absence of specific pathogens, conditions, or biomarkers, typically providing results within minutes to a few hours. These tests are frequently utilized at the point of care, facilitating prompt clinical decisions, early intervention, and improved patient outcomes.

The main product types in rapid diagnostics include kits, reagents, instruments, and other related products. Kits are pre-assembled diagnostic tools that contain all necessary components-such as reagents, assay devices, and instructions-for conducting specific tests accurately and efficiently. Rapid diagnostics are performed using various platforms, including immunoassays, molecular detection methods, and other technologies. They are applied across a range of testing areas such as blood glucose monitoring, infectious disease screening, cardiometabolic testing, pregnancy and fertility testing, fecal occult blood testing, coagulation testing, and toxicology screening. These diagnostic tools are distributed through multiple channels, including hospital pharmacies, physical retail stores, e-commerce platforms, and other outlets. Key end users include diagnostic laboratories, homecare settings, hospital pharmacies, and other healthcare providers.

The rapid diagnostics market research report is one of a series of new reports from The Business Research Company that provides rapid diagnostics market statistics, including the rapid diagnostics industry global market size, regional shares, competitors with the rapid diagnostics market share, detailed rapid diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the rapid diagnostics industry. This rapid diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The rapid diagnostics market size has grown rapidly in recent years. It will grow from $32.01 billion in 2024 to $36.08 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. This historical growth was driven by the increasing burden of infectious diseases, expanding utilization of point-of-care diagnostics, growing issues with antimicrobial resistance, heightened awareness of early disease detection, and rising healthcare investments in developing nations.

The rapid diagnostics market size is expected to see rapid growth in the next few years. It will grow to $57.71 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. Key drivers for this projected growth include the rising popularity of personalized healthcare, growing implementation of AI-driven diagnostic tools, increasing consumer preference for at-home testing options, escalating healthcare infrastructure development, and a stronger emphasis on pandemic response strategies. Prominent trends anticipated during the forecast period encompass enhancements in microfluidic technologies, breakthroughs in biosensor diagnostics, integration of mobile apps with testing tools, progress in lab-on-a-chip innovations, and the evolution of multiplex diagnostic platforms.

The growing prevalence of infectious diseases is expected to drive the expansion of the rapid diagnostics market. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which can spread from one person to another either directly or indirectly. The increase in infectious disease cases is largely attributed to greater global travel, which facilitates faster transmission and higher infection rates. Rapid diagnostics play a critical role by enabling the quick and accurate identification of pathogens, which supports timely treatment decisions, minimizes transmission, and improves patient outcomes. For example, in May 2025, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, reported that global SARS-CoV-2 activity has been increasing since mid-February 2025. According to data from sentinel sites, the test positivity rate reached 11%, a level last observed in July 2024. As such, the rising prevalence of infectious diseases is contributing to the growth of the rapid diagnostics market.

Key players in the rapid diagnostics market are prioritizing innovation and advancements, particularly in the development of rapid diagnostic testing tools that enhance accuracy, reduce turnaround times, and improve patient care in point-of-care environments. Rapid diagnostic testing tools are medical devices that swiftly detect the presence of specific diseases or conditions, often delivering results within minutes. For example, in May 2025, SEKISUI Diagnostics, a US-based medical diagnostics manufacturer, introduced the OSOM RSV Test, a rapid diagnostic tool designed to detect respiratory syncytial virus (RSV). This test is intended for professional healthcare settings and provides results in just 15 minutes. It utilizes a rapid immunochromatographic assay to qualitatively detect RSV nucleoprotein antigen from anterior nasal swab specimens taken from symptomatic patients. The rapid results support timely and effective clinical decision-making.

In June 2023, Avacta Group, a UK-based biotechnology company, acquired Coris Bioconcept SRL for an undisclosed sum. With this acquisition, Avacta Group seeks to broaden its diagnostics portfolio and strengthen its capabilities in rapid testing technologies for infectious diseases and antimicrobial resistance. Coris Bioconcept SRL is a Belgium-based biotechnology firm specializing in the development, production, and marketing of rapid diagnostic tests.

Major players in the rapid diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux S.A., QuidelOrtho Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., OraSure Technologies Inc., Nova Biomedical Corporation, Fujirebio Holdings Inc., Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Abingdon Health plc, Abionic SA.

North America was the largest region in the rapid diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rapid diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the rapid diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rapid diagnostics market includes revenues earned by providing services such as quick and accurate testing for diseases, infections, and medical conditions using point-of-care diagnostic tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The rapid diagnostics market consists of sales of quick diagnostic test kits and devices used for the rapid detection of diseases and medical conditions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rapid Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rapid diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rapid diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rapid diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Kits; Reagents; Instruments; Other Product Types
• 2) By Platform: Immunoassays; Molecular Detection; Other Rapid Diagnostic Platforms
• 3) By Application: Blood Glucose Testing; Infectious Disease Testing; Cardiometabolic Testing; Pregnancy and Fertility Testing; Fecal Occult Blood Testing; Coagulation Testing; Toxicology Testing
• 4) By Distribution Channel: Hospital Pharmacies; Brick and Mortar; E-Commerce; Other Distribution Channels
• 5) By End Use: Diagnostic Centers; Homecare Settings; Hospital Pharmacies; Other End Users
• Subsegments:
• 1) By Kits: Lateral Flow Assay Kits; PCR Kits; Immunoassay Kits; Microfluidic Kits; Molecular Diagnostic Kits; Multiplex Kits
• 2) By Reagents: Enzymes; Buffers; Probes and Primers; Stains and Dyes; Antibodies; Calibration and Control Reagents
• 3) By Instruments: PCR Machines; Lateral Flow Readers; Immunoassay Analyzers; Microfluidic Analyzers; Automated Sample Processors; Biosensors
• 4) By Other Product Types: Software and Data Management Tools; Sample Collection Devices; Accessories and Consumables; Calibration Standards; Point-of-Care Devices
• Companies Mentioned: Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rapid Diagnostics Market Characteristics

3. Rapid Diagnostics Market Trends And Strategies

4. Rapid Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Rapid Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Rapid Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Rapid Diagnostics Market Growth Rate Analysis
• 5.4. Global Rapid Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Rapid Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Rapid Diagnostics Total Addressable Market (TAM)

6. Rapid Diagnostics Market Segmentation

• 6.1. Global Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits
• Reagents
• Instruments
• Other Product Types
• 6.2. Global Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassays
• Molecular Detection
• Other Rapid Diagnostic Platforms
• 6.3. Global Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Glucose Testing
• Infectious Disease Testing
• Cardiometabolic Testing
• Pregnancy And Fertility Testing
• Fecal Occult Blood Testing
• Coagulation Testing
• Toxicology Testing
• 6.4. Global Rapid Diagnostics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Brick And Mortar
• E-Commerce
• Other Distribution Channels
• 6.5. Global Rapid Diagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Centers
• Homecare Settings
• Hospital Pharmacies
• Other End Users
• 6.6. Global Rapid Diagnostics Market, Sub-Segmentation Of Kits,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lateral Flow Assay Kits
• PCR Kits
• Immunoassay Kits
• Microfluidic Kits
• Molecular Diagnostic Kits
• Multiplex Kits
• 6.7. Global Rapid Diagnostics Market, Sub-Segmentation Of Reagents,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Buffers
• Probes And Primers
• Stains And Dyes
• Antibodies
• Calibration And Control Reagents
• 6.8. Global Rapid Diagnostics Market, Sub-Segmentation Of Instruments,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Machines
• Lateral Flow Readers
• Immunoassay Analyzers
• Microfluidic Analyzers
• Automated Sample Processors
• Biosensors
• 6.9. Global Rapid Diagnostics Market, Sub-Segmentation Of Other Product Types,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software And Data Management Tools
• Sample Collection Devices
• Accessories And Consumables
• Calibration Standards
• Point-Of-Care Devices

7. Rapid Diagnostics Market Regional And Country Analysis

• 7.1. Global Rapid Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Rapid Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rapid Diagnostics Market

• 8.1. Asia-Pacific Rapid Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rapid Diagnostics Market

• 9.1. China Rapid Diagnostics Market Overview
• 9.2. China Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rapid Diagnostics Market

• 10.1. India Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rapid Diagnostics Market

• 11.1. Japan Rapid Diagnostics Market Overview
• 11.2. Japan Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rapid Diagnostics Market

• 12.1. Australia Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rapid Diagnostics Market

• 13.1. Indonesia Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rapid Diagnostics Market

• 14.1. South Korea Rapid Diagnostics Market Overview
• 14.2. South Korea Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rapid Diagnostics Market

• 15.1. Western Europe Rapid Diagnostics Market Overview
• 15.2. Western Europe Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rapid Diagnostics Market

• 16.1. UK Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rapid Diagnostics Market

• 17.1. Germany Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rapid Diagnostics Market

• 18.1. France Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rapid Diagnostics Market

• 19.1. Italy Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rapid Diagnostics Market

• 20.1. Spain Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rapid Diagnostics Market

• 21.1. Eastern Europe Rapid Diagnostics Market Overview
• 21.2. Eastern Europe Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rapid Diagnostics Market

• 22.1. Russia Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rapid Diagnostics Market

• 23.1. North America Rapid Diagnostics Market Overview
• 23.2. North America Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rapid Diagnostics Market

• 24.1. USA Rapid Diagnostics Market Overview
• 24.2. USA Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rapid Diagnostics Market

• 25.1. Canada Rapid Diagnostics Market Overview
• 25.2. Canada Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rapid Diagnostics Market

• 26.1. South America Rapid Diagnostics Market Overview
• 26.2. South America Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rapid Diagnostics Market

• 27.1. Brazil Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rapid Diagnostics Market

• 28.1. Middle East Rapid Diagnostics Market Overview
• 28.2. Middle East Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rapid Diagnostics Market

• 29.1. Africa Rapid Diagnostics Market Overview
• 29.2. Africa Rapid Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Rapid Diagnostics Market, Segmentation By Platform, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Rapid Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rapid Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Rapid Diagnostics Market Competitive Landscape
• 30.2. Rapid Diagnostics Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Rapid Diagnostics Market Other Major And Innovative Companies

• 31.1. Siemens Healthineers AG
• 31.2. Becton Dickinson and Company
• 31.3. Quest Diagnostics Incorporated
• 31.4. Hologic Inc.
• 31.5. bioMerieux S.A.
• 31.6. QuidelOrtho Corporation
• 31.7. Bio-Rad Laboratories Inc.
• 31.8. QIAGEN N.V.
• 31.9. Cepheid Inc.
• 31.10. OraSure Technologies Inc.
• 31.11. Nova Biomedical Corporation
• 31.12. Fujirebio Holdings Inc.
• 31.13. Sekisui Diagnostics LLC
• 31.14. EKF Diagnostics Holdings plc
• 31.15. Trinity Biotech plc

32. Global Rapid Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rapid Diagnostics Market

34. Recent Developments In The Rapid Diagnostics Market

35. Rapid Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Rapid Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Rapid Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Rapid Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer